Various types of stem cells reside in the body and selfrenew throughout an organism's lifetime. Such self-renewal is essential for maintenance of tissue homeostasis and is co-ordinately regulated by stem cell-intrinsic signals and signals from stem cell niche. Angiopoietin is a niche-derived signalling molecule well known to contribute to maintenance of haematopoietic stem cells (HSCs). Angiopoietin-like proteins (ANGPTLs) are structurally similar to angiopoietin, and recent studies reveal that they function in angiogenesis, lipid and energy metabolism and regulation of inflammation. However, unlike angiopoietins, activities of ANGPTLs in stem cell maintenance have remained unclear. Recently, several studies have reported an association of ANGPTL signalling with stem cell maintenance. Here, we summarize those findings with a focus on HSCs, intestinal stem cells, neural stem cells and cancer stem cells and discuss mechanisms underlying ANGPTL-mediated stem cell maintenance.
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Stem cells are characterized by their capacity for selfrenewal and their pluripotency. Such self-renewal capacity is essential for maintenance of tissue homeostasis. Cell-intrinsic signals as well as signals from the microenvironment surrounding stem cells (stem cell niches) coordinately regulate stem cell activity (1) . Various cell types in each tissue comprise the niche and express numerous signalling molecules, including humoral factors, cell adhesion molecules and extracellular matrix (ECM), all playing important roles in stem cell maintenance (2) .
Angiopoietin-like proteins (ANGPTLs) are secreted proteins that structurally resemble angiopoietin (Fig. 1) . The angiopoietin family protein Angiopoietin-1 (Ang-1) is composed of two N-terminal coiled-coil domains and a C-terminal fibrinogen-like domain (Fig. 1) , the latter essential for binding to the angiopoietin receptor Tie2 (3). Ang-1-Tie2 signalling is well known to play important roles in angiogenesis and maintenance of haematopoietic stem cells (HSCs; 4). Like angiopoietins, most ANGPTLs reportedly function in angiogenesis (5) . However, while seven of the eight ANGPTL family proteins (ANGPTLs 17) exhibit a C-terminal fibrinogen-like domain (Fig. 1) , they do not bind Tie2 (6) . Several studies report that ANGPTLs function in lipid and energy metabolism and in regulation of inflammation (5, 7) . For example, ANGPTL2 functions in tissue repair by accelerating angiogenesis and tissue remodelling (7). However, excess ANGPTL2 signalling promotes chronic inflammation and subsequent irreversible tissue remodelling and is associated with development of lifestyle-related diseases and cancers (7) . ANGPTL6 also promotes tissue repair and angiogenesis (8, 9) and antagonizes obesity-induced metabolic disease by enhancing systemic energy metabolism (10) . ANGPTL3 and ANGPTL4 contribute to lipid metabolism by inhibiting lipoprotein lipase activity (5) . The N-terminal coiled-coil domain of ANGPTL3 or ANGPTL4 is reportedly essential for inhibition of lipoprotein lipase activity, and when cleaved from the protein those N-terminal fragments more effectively inhibit lipoprotein lipase activity than does the full-length protein (5) . Finally, recent work demonstrates that ANGPTL8, which lacks a Cterminal fibrinogen-like domain, regulates lipid metabolism by facilitating processing of ANGPTL3 (11) . However, despite these investigations of ANGPTL function in physiology and pathophysiology, an association between ANGPTL signalling and stem cell activity has remained unclear. In this review, we summarize recent studies that suggest such a function with particular attention to HSCs, intestinal stem cells (ISCs), neural stem cells (NSCs) and cancer stem cells (CSCs).
Haematopoietic Stem Cells
HSCs produce all blood cell lineages throughout an organism's lifetime, and their self-renewal, quiescence, proliferation and differentiation are regulated by bone marrow niche-derived signals (4). Ang-1-Tie2 activity is a well-characterized bone marrow niche-derived signal and is reportedly required for HSC maintenance and survival (4) . Tie2 is expressed on HSCs, while Ang-1 is predominantly expressed in stromal cells in bone marrow, such as osteoblastic cells and mesenchymal stem/stromal cells (4, 12) . Bone marrow nichederived Ang-1 activates b1 integrin and N-cadherin in HSCs via Tie2, thereby promoting HSC interaction with niche components, such as ECM and stromal cells. These interactions promote HSC quiescence and self-renewal ( Fig. 2; 12, 13) .
Some ANGPTLs also function in HSC maintenance, as reported by Zhang et al. (14) . That study showed that treatment of mouse HSCs with ANGPTLs 2, 3, 4, 5 or 7 facilitates their ex vivo expansion. Subsequently, several studies showed that these same ANGPTLs promote ex vivo expansion of human cord blood HSCs (1519). Interestingly, leukocyte immune-like receptor B2 (LILRB2), an immuneinhibitory receptor expressed on macrophages and B cells, reportedly functions as an ANGPTL receptor (20) . Among ANGPTL family proteins, ANGPTL2 and ANGPTL5 more specifically bind to LILRB2 and its mouse orthologue paired immune-like receptor B (PirB) as compared to other ANGPTLs (20) . Both LILRB2 and PirB are highly expressed in HSCs relative to progenitor or lineage-marker + cells (20) , and ANGPTL2 or ANGPTL5 treatment has no effect on re-population activity of cultured LILRB2-knockdown human cord blood HSCs or PirB-deficient mouse HSCs (20) , suggesting that this receptor is required for ANGPTL2-or ANGPTL5-mediated ex vivo HSC expansion. Moreover, in HSCs ANGPTL5 promotes recruitment of SHP-1 and SHP-2 to the PirB intracellular domain and activation of calcium/calmodulin-dependent protein kinase (CAMK) 2 and CAMK4 (20) . Because SHP-2 and CAMK4 are required for HSC re-populating activity (21, 22) , ANGPTL2 and ANGPTL5 signalling via LILRB2 likely enhances HSC self-renewal capacity (Fig. 2) . Moreover, a recent study showed that ANGPTL2 promotes interaction of LILRB2 with Notch and activation of Notch signalling in human cord blood HSCs (23) . Notch signalling reportedly regulates HSC selfrenewal and quiescence (4) . Thus, Notch activation may be implicated in ANGPTL2-LILRB2 signallingmediated HSC maintenance (Fig. 2) .
Treatment with ANGPTL3 stimulates ex vivo expansion of mouse and human HSCs (14, 19) , while its function in HSC maintenance in vivo has not been investigated. A recent study showed that Angptl3-deficient mice show a decrease in frequency and quiescence of HSCs in bone marrow (24) . Moreover, re-population activity of wild-type HSCs transplanted into bone marrow of Angptl3-deficient recipient mice is impaired (24) , suggesting that bone marrow niche-derived ANGPTL3 is required for HSC maintenance. Interestingly, among CD45 bone marrow cells, sinusoidal endothelial cells express high levels of ANGPTL3 and Angptl3-deficient bone marrow endothelial cells cannot support HSC re-population activity (24) . The transcription factor Ikaros plays an important role in haematopoiesis (25) , but its overexpression in HSCs decreases HSC re-populating activity (24) . ANGPTL3 treatment decreases Ikaros expression in HSCs, thereby maintaining HSC stemness ( Fig. 2;  24) . In addition, stem cell factor (SCF) + delta-like 1 (DLK) + foetal liver cells and stromal cells reportedly express high levels of ANGPTL3 and high expression of ANGPTL3 has been shown to facilitate HSC expansion in foetal liver (26) . These findings suggest that niche cell-derived ANGPTL3 maintains HSC stemness in the context of both bone marrow and foetal liver.
A recent study showed that Angptl7-deficient mice exhibit decreased numbers of HSCs and haematopoietic progenitor cells in bone marrow and foetal liver (27) . In bone marrow transplant experiments, the re-populating activity of Angptl7-deficient HSCs was comparable to that of wild-type HSCs when wild-type mice served as recipients (27) . However, when wild-type HSCs were transplanted into Angptl7-deficient recipients HSCs showed decreased re-populating activity (27) , suggesting that like ANGPTL3, niche-derived ANGPTL7 is indispensable for HSC maintenance. Recently, Xiao et al. reported that ANGPTL7 increases expression of C-X-C chemokine receptor type 4 (CXCR4), homeobox B4 (HOXB4) and Wnt signalling target genes in human cord blood HSCs (17) . CXCR4 and HOXB4 reportedly play important roles in HSC homing and self-renewal, respectively (28, 29) . Wnt signalling also contributes to HSC maintenance (30) . Interestingly, ANGPTL7-treated HSCs show accelerated ex vivo expansion and enhanced homing ability to the bone marrow and spleen of recipient mice. Moreover, ANGPTL7 effects on HSCs are blocked by treatment with anti-CXCR4 antibody or with Wnt inhibitors (17) . These findings suggest overall that niche-derived ANGPTL7 supports HSCs maintenance by up-regulating expression of CXCR4 and HOXB4 and activating Wnt signalling in HSCs (Fig. 2) .
Like Ang-1, ANGPTL3 and ANGPTL7 also function as niche-derived signals that regulate HSCs stemness. However, a recent study showed that ANGPTL2 is secreted from HSCs (31), suggesting that ANGPTL2 regulates HSC stemness of HSC cell-autonomously. However, unlike ANGPTL2 and ANGPTL5, other ANGPTLs bind poorly to LILRB2 (20) and receptors for these factors in HSCs have not yet been identified. Several studies report that integrins function as ANGPTL receptors in non-haematopoietic cells, such as endothelial cells, fibroblasts and tumour cells (3237). For example, ANGPTL2 stimulates endothelial cell adhesion and migration via integrin a5b1 (32). Interestingly, HSCs also express various types of integrins that reportedly function in HSC regulation (2, 38). Therefore, ANGPTL signalling via integrins is implicated in HSC maintenance. Further studies are needed to investigate this possibility.
Intestinal Stem Cells
The intestinal lumen is exposed to various external and internal stresses that cause mucosal injury. To repair this damage and maintain intestinal homeostasis, the intestinal epithelium undergoes rapid regeneration after injury, an activity regulated by proliferation and differentiation of ISCs. Opposing gradients of Wnt/bcatenin and bone morphogenetic protein (BMP) signalling reportedly regulate ISC fate: Wnt/b-catenin signalling is highest at the crypt base, where it facilitates ISC self-renewal, whereas BMP signalling, which is highest at the lumen surface, inhibits ISC self-renewal (39) .
Angptl2-deficient mice exhibit no abnormalities in intestinal tissues, indicating that ANGPTL2 is dispensable for normal homeostasis. In a dextran sulphate sodium-induced mouse colitis model, Angptl2 expression in intestinal tissues of wild-type mice increased after tissue injury, while compared with wild-type mice, Angptl2-deficient mice showed impaired regeneration of the intestinal epithelium after injury (34) . In addition, expression levels of ISC marker genes, such as leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) and achaete-scute homolog 2 (Ascl2), markedly decrease in crypts of Angptl2-deficient relative to wild-type mice (34) . Active-b-catenin levels also decrease in crypts of Angptl2-deficient mice (34) . These findings suggest that ANGPTL2 contributes to ISC maintenance during intestinal tissue regeneration.
ANGPTL2 is abundantly expressed in intestinal sub-epithelial myofibroblasts (ISEMFs), which reside near the crypt base and reportedly function in stem cell maintenance, but not in intestinal epithelial cells (34) . Angptl2-deficient ISEMFs show significantly increased expression of Bmp2 and Bmp7 compared to wild-type ISEMFs (34) . Furthermore, ISEMFs express integrin a5b1 protein, and Bmp2 and Bmp7 transcript levels in ISEMFs treated with integrin a5b1 antibody significantly increase compared with those seen in untreated ISEMFs (34) . ANGPTL2-integrin a5b1 signalling activates nuclear factor-kB (NF-kB; 7), and NF-kB inhibition in ISEMFs up-regulates Bmp2 and Bmp7 (34). These findings suggest that ISEMF-derived ANGPTL2 activates the integrin a5b1-NF-kB pathway in an autocrine manner to inhibit Bmp2 and Bmp7 induction in ISEMFs. Therefore, ANGPTL2 maintains a microenvironment supportive of ISC stemness by modulating competing Wnt/b-catenin and BMP signals and promoting ISC self-renewal and subsequent tissue repair (Fig. 3) .
Cancer Stem Cells
Acute myeloid leukaemia (AML) cells originate from HSCs and produce an aberrantly large number of immature white blood cells in bone marrow, impairing production of normal blood cells. ANGPTL signalling is reportedly implicated not only in HSC maintenance but in leukaemia development (20) . Zheng et al. found that LILRB2 expression on human acute monoblastic and monocytic leukaemia cells, which represent AML subtypes, is significantly higher than on other AML cells (20) . In a leukaemia mouse model, in which mice transplanted with lineage-marker bone marrow cells transduced with an AML causative gene (such as MLL-AF9 or AML1-ETO9a) develop AML (40), mice transplanted with fusion gene-transduced, PirB-deficient donor cells exhibited a decreased number of AML cells, an increase in differentiated cells and prolonged survival compared to mice implanted with PirB-expressing donor cells (20) , suggesting that PirB signalling contributes to leukaemia development. In addition, ANGPTL2 and ANGPTL5 promote self-renewal of wild-type AML cells, while growth of PirBdeficient AML cells is not enhanced by ANGPTL treatment (20) . A recent study demonstrated that impaired AML development seen in mice transplanted with MLL-AF9-transduced, PirB-deficient donor cells is rescued by overexpression of Camk1 or Camk4 (41). Furthermore, mice transplanted with MLL-AF9-transduced, Camk4-deficient donor cells showed retarded AML development and decreased self-renewal capacity of AML stem cells (41) . CAMK knockdown also suppresses proliferation of human AML cell lines (41) . Taken together, these findings suggest that ANGPTL-LILRB2/PirB-CAMK signalling is essential for AML development and the maintenance of stemness of AML stem cells. Because AML stem cells are resistant to chemotherapy, most patients with AML relapse after treatment. The studies reviewed here suggest that suppressing ANGPTL-LILRB signalling may represent a novel therapeutic approach against AML.
ANGPTL2 signalling facilitates metastasis of various types of solid tumours (33, 35, 42, 43) . We have shown that cancer cell-derived ANGPTL2 accelerates metastasis of lung cancer, breast cancer, skin cancer and osteosarcoma by increasing tumour cell motility and invasiveness (33, 42, 43) . We also reported that ANGPTL2 functions in development of colorectal cancer cell resistance to chemotherapy (35) . Because tumour metastasis and chemoresistance are closely associated with CSC activity (44) , ANGPTL2 signalling may underlie aggressive tumour cell behaviour not only in leukaemia but also solid tumours.
Neural Stem Cells
Angiopoietin-Tie2 signalling reportedly stimulates growth of NSCs in vitro (45) . Ang-2 enhances induction of NSC renewal by delta-like 4 (Dll4), a Notch ligand (45) . Moreover, Ang-2 increases expression of hairy and enhancer of split3 (Hes3) in NSCs by activating STAT3 (45) . Because STAT3 reportedly up-regulates not only Hes3 but also sonic hedgehog (Shh), which induces angiopoietin expression, in NSCs (45, 46) , the Ang-2-STAT3-Hes3-Shh feedback loop may accelerate NSC self-renewal. On the other hand, an association between ANGPTLs and NSCs has not been reported. However, a recent study demonstrated that PirB signalling contributes to NSC regulation (47) . NSCs reside in the ventricular zone (VZ) and sub-ventricular zone (SVZ) of the brain (48) . NogoA, a myelin-related protein expressed in the VZ, reportedly functions as a PirB ligand and facilitates NSC survival and proliferation by activating SHP1/2 signalling (47) . Since ANGPTL2 and ANGPTL5 also activate the PirB-SHP1/2 pathway (20) , ANGPTL signalling via PirB may stimulate NSC survival and proliferation. However, further studies are needed to 
Conclusion
In this review, we have focused on ANGPTL function in stem cell maintenance. Similar to angiopoietins, some ANGPTLs, such as ANGPTL3 and ANGPTL7, are expressed in the stem cell niche and contribute to regulation of HSC self-renewal. On the other hand, ANGPTL2 supports stemness of both normal HSCs and leukaemia stem cells in an autocrine manner. Since these factors are critical for HSC maintenance, crosstalk among ANGPTL signalling pathways may be an important regulator of HSC activity. However, except for ANGPTL2 and ANGPTL5, receptors for ANGPTLs contributing to stem cell maintenance have not yet been characterized. Therefore, to further understand ANGPTL physiological or pathophysiological function in stem cell maintenance, it is important to identify ANGPTL receptors and their downstream signalling pathways.
Recent studies implicate ANGPTLs in maintenance of various types of tissue stem cells, including HSCs and ISCs. All ANGPTLs enhance stem cell self-renewal although the mechanisms may vary. Thus, ANGPTLs may prevent stem cell exhaustion due to the stress of aging or tissue damage by facilitating stem cell self-renewal, thereby contributing to stem cell maintenance in each tissue.
Impaired activity of stem cells or the niche is a hallmark of aging that has received much attention as underlying age-related diseases, such as cancer and sarcopenia, the latter an age-related skeletal muscle atrophy (49, 50). Leukaemia incidence is also higher in the elderly and, as described here, ANGPTL2 and ANGPTL5 activity contributes to that cancer. Interestingly, ANGPTL2 expression levels in various cell types, such as cardiomyocytes, endothelial cells, skeletal myocytes and T cells and as well as circulating ANGPTL2 levels increase with age (5154). Moreover, we recently showed that ANGPTL2 expression in skeletal myocytes increases with age and that increased ANGPTL2 inactivates satellite cells, which function as skeletal muscle stem/progenitor cells, by inducing inflammation and promoting reactive oxygen species (ROS) accumulation in skeletal muscle, thereby accelerating sarcopenia development ( Fig. 4; 53) . Thus, changes in ANGPTL signalling in stem or niche cells are implicated in aging phenotypes seen in stem cells, an outcome worthy of future investigations. ANGPTL activity in stem cell maintenance
